Tag: ARVs for prevention
Awareness of, willingness to take PrEP and its actual use among Belgian MSM at high risk of HIV infection: secondary analysis of the Belgian European MSM internet survey
AIDS and Behavior, published online first 24 November 2021 (doi: 10.1007/s10461-021-03526-z).
Measures of HIV pre‐exposure prophylaxis uptake among gay, bisexual, and other men who have sex with men in Canada and demographic disparities among those at elevated likelihood for HIV acquisition
AIDS and Behavior, 2021; 25:3638–3650 (doi: 10.1007/s10461-021-03336-3).
Are PrEP services in France reaching all those exposed to HIV who want to take PrEP? MSM respondents who are eligible but not using PrEP (EMIS 2017)
AIDS Care 2020; 32(2):47-56 (doi: 10.1080/09540121.2020.1739219).
Estimating the ‘PrEP Gap’: how implementation and access to PrEP differ between countries in Europe and Central Asia in 2019
Eurosurveillance, 2019; 24(41) (doi: 10.2807/1560-7917).
Understanding user perspectives of and preferences for oral PrEP for HIV prevention in the context of intervention scale-up: a synthesis of evidence from sub-Saharan Africa
Journal of the International AIDS Society, 2019 July, 22(S4):e25306 (doi: 10.1002/jia2.25306).
What qualities in a potential HIV pre-exposure prophylaxis service are valued by black men who have sex with men in London? A qualitative acceptability study
International Journal of STD & AIDS, 2018; 29(8): 760–765 (doi:10.1177/0956462418755224).
Non-condom related strategies to reduce the risk of HIV transmission: Perspectives and experiences of gay men with diagnosed HIV
Journal of Health Psychology, 2016; 21(11):2562-2571 (doi:10.1177/1359105315581066).
Protocol for a systematic review: understanding the motivations and barriers to uptake and use of female-initiated, primary biomedical HIV prevention technologies in sub-Saharan Africa
Systematic Reviews, 2015, 4:111 (doi:10.1186/s13643-015-0096-1)
Pharmaceutical HIV prevention technologies in the UK: six domains for social science research
AIDS Care, 2015, 27:6, 796-803 (doi:10.1080/09540121.2014.989484).
Positive benefits: preventive impact of post-exposure prophylaxis awareness among those with diagnosed HIV
Sexually Transmitted Infections, 2008, 84:92-93 (doi:10.1136/sti.2007.026211).
Prevalence of PrEP use and modes of access in 42 European countries, Lebanon, Israel and Canada
(Axel J. Schmidt)
AIDS Impact, London, England, 31 July 2019
European MSM Internet Survey 2017: Response, Demographics, Chemsex, PrEP
(Axel J. Schmidt & Peter Weatherburn)
22nd International AIDS Conference (AIDS 2018), Amsterdam, Netherlands, July 23-27, 2018
Motivations and barriers to pre-exposure prophylaxis (PrEP) use among black men who have sex with men (MSM) aged 18-45 in London
After PrEP: Ethical Sexualities, Viral Memories, and New Socio-Medical Landscapes in HIV Prevention, University of Sussex, 2-3 June 2016
ARVs for prevention: a research agenda for the social sciences
(Catherine Dodds, Adam Bourne, Peter Weatherburn and others)
IAPAC Controlling the HIV Epidemic with Antiretrovirals, London, 22-24 September 2013 (Plenary)
Professional ambivalence: the views of HIV service providers about ARVs for prevention in 3 settings
(Catherine Dodds, Asha Persson, E. Vernooijc)
IAPAC Controlling the HIV Epidemic with Antiretrovirals, London, 22-24 September 2013 (Poster).
Perceptions of HIV treatment as prevention among African people in sero-discordant relationships
(Adam Bourne, Catherine Dodds; Jabulani Chwaula; Peter Weatherburn)
XIX International AIDS Conference, Washington D.C, 25 July 2012 (Poster).